Page 5 - Generation Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

All the latest martech and adtech news from Freshworks, NielsenIQ, Optimove, Bigeye, ActionIQ, Blackbird.AI, Litmus and Talkwalker

Blue J, the leading provider of predictive analysis tools for tax positions, today announces that the company has raised US$9M in Series B financing led by Generation Ventures.

Algolux, a Montreal, QC, Canada-based computer vision software company, raised $18.4M in Series B funding. The round was led by Forte Ventures and Drive Capital with participation from Investissement Quebec, Castor Ventures, Nikon-SBI Innovation Fund, GM Ventures, Generation Ventures and Intact Ventures. As part of the funding round, Louis Rajczi, Partner at Forte Ventures, and Alistair Mitchell, President at Generation Ventures have joined the Algolux Board of Directors. Alan MacIntosh, Board Partner at Real Ventures, will be moving to a Board Observer role. The company intends to use the...

Sponsored Links Algolux, an AI software company based out of Quebec, has announced the closure of series B funding, raising $18.4 million to help accelerate market adoption of the company’s scalable computer vision and image optimization solutions. GM Ventures was among the companies leading this investment round. The other companies leading the series B funding round included Forte Ventures, Drive Capital, Investissement Quebec, Castor Ventures, Nikon-SBI Innovation Fund, Generation Ventures, and Intact Ventures. GM Ventures initially invested in Algolux in 2018, pouring millions into the ...

Share this article Share this article SAN DIEGO, April 29, 2021 /PRNewswire/ -- i2020, an accelerator program backed by the San Diego-based venture company Torrey Pines Investment, has announced multiple start-up and follow-on investment rounds together with OrbiMed and a start-up investment in a European science-based venture, together with OrbiMed and BioGeneration Ventures (BGV). The proceeds of the follow-ons will be used to further support the three previously funded, oncology-focused companies - Lomond Therapeutics, Eil Therapeutics and Ness Therapeutics and the start-up proceeds will f...